Related Experiment Video
Updated: Jul 9, 2025

10:33
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
1.3K
Cellular Responses to Extracellular Vesicles as Potential Markers of Colorectal Cancer Progression
Sonia Guarnerio1, Robert Tempest2, Rawan Maani1
1Biomolecular Sciences Research Centre, Sheffield Hallam University, Sheffield S1 1WB, UK.
International Journal of Molecular Sciences
|December 9, 2023
Summary
Novel cancer screening tests may use cellular responses to extracellular vesicles (EVs) alongside EV biomarkers. This approach aids in early diagnosis and patient subtyping for colorectal cancer (CRC) by analyzing stage-dependent cellular changes.
Area of Science:
- Oncology
- Biomarker Discovery
- Cellular Biology
Background:
- Early cancer diagnosis and patient subtyping are crucial for effective treatment, especially in heterogeneous cancers like colorectal cancer (CRC).
- Extracellular vesicles (EVs) in bodily fluids show promise as biomarkers, but standardization issues and inherent heterogeneity hinder clinical use.
- Standardized EV isolation and analysis are needed for reliable detection of disease markers.
Purpose of the Study:
- To explore cellular responses to cancer EVs as complementary biomarkers for colorectal cancer (CRC) stage separation.
- To investigate the potential of combining EV biomarkers with cellular responses for improved diagnostic accuracy.
- To assess the clinical utility of cellular responses to plasma-derived EVs in a pilot study.
Main Methods:
- Utilized colorectal cancer (CRC) cell line models (SW480 and SW620) to study cellular responses to cancer EVs.
- Performed multivariate analysis on cellular responses to plasma-derived EVs from a pilot cohort of CRC patients and controls.
- Integrated plasma EV markers with cellular response data for advanced patient stratification.
Main Results:
- Cancer EVs influenced cell activities and tumor microenvironment pathways in a stage-dependent manner in cell line models.
- Cellular responses to plasma-derived EVs showed distinct patterns related to disease stage.
- Multivariate analysis combining EV markers and cellular responses successfully separated CRC patients by disease stage.
Conclusions:
- Cellular responses to EVs represent a promising complementary biomarker approach for cancer screening.
- Combining EV biomarkers with analysis of cellular responses to EVs can enhance diagnostic capabilities for CRC.
- This preliminary study supports the development of novel screening methods integrating EV-based and cellular response biomarkers.

